Anthracycline News and Research

RSS
Anthracycline is a type of antibiotic that comes from certain types of Streptomyces bacteria. Anthracyclines are used to treat many types of cancer. Anthracyclines damage the DNA in cancer cells, causing them to die. Daunorubicin, doxorubicin, and epirubicin are anthracyclines.
SwRI collaborates with UTSA to develop novel chemical process for synthesizing antibiotics

SwRI collaborates with UTSA to develop novel chemical process for synthesizing antibiotics

DASH diet may lower the risk of cardiovascular disease in breast cancer survivors

DASH diet may lower the risk of cardiovascular disease in breast cancer survivors

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

ACE inhibitors show no benefit in reducing chemotherapy-induced heart damage

Genetic test can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy

Genetic test can identify how patients with triple negative early-stage breast cancer will respond to immunotherapy

Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors

Simple biomarkers offer early warning of hidden heart risk in childhood cancer survivors

Carvedilol improves heart health marker in childhood cancer survivors

Carvedilol improves heart health marker in childhood cancer survivors

Childhood cancer treatment linked to higher breast cancer risk

Childhood cancer treatment linked to higher breast cancer risk

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

ER-phagy alleviates drug-induced cardiomyopathy in cancer patients

Case report and review of a novel chromosomal abnormality in AML patient

Case report and review of a novel chromosomal abnormality in AML patient

Young adult cancer survivors at higher risk of heart failure when treated with anthracyclines

Young adult cancer survivors at higher risk of heart failure when treated with anthracyclines

ACC to host annual Advancing the Cardiovascular Care of the Oncology Patient course

ACC to host annual Advancing the Cardiovascular Care of the Oncology Patient course

Researchers discover a protein linked with the onset of anthracycline-associated cardiac toxicity

Researchers discover a protein linked with the onset of anthracycline-associated cardiac toxicity

IU researchers uncover new ways to prevent serious side effects for breast cancer patients

IU researchers uncover new ways to prevent serious side effects for breast cancer patients

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Inhibiting inflammatory signaling pathway could reduce the chances of heart disease in cancer survivors

Penn State researchers lay the foundation for precision fabrication of tumor models

Penn State researchers lay the foundation for precision fabrication of tumor models

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

Did the diagnosis and management of Hodgkin lymphoma differ during the SARS-CoV-2 pandemic?

Study estimates the cost-effectiveness of therapeutic alternatives

Study estimates the cost-effectiveness of therapeutic alternatives

New advice aims to reduce the cardiac side effects of cancer treatment

New advice aims to reduce the cardiac side effects of cancer treatment

Machine learning and proteomics predict cardiovascular risk more accurately

Machine learning and proteomics predict cardiovascular risk more accurately

Vitamin C may help to counteract common side effect of the chemotherapy drug

Vitamin C may help to counteract common side effect of the chemotherapy drug

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.